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Cardiac resynchronization therapy (CRT) has been estab-lished as a useful therapy for patients with heart failure 
with abnormal QRS duration and low ejection fraction (EF). 
Although the vast majority of patients treated with CRT have 
a left bundle branch block (LBBB) QRS morphology, since 
the introduction of CRT into clinical practice, a growing num-
ber of patients with right bundle branch block (RBBB) QRS 
morphology or diffuse intraventricular conduction abnor-
mality have been treated.1–19 As shown in Table 1, the most 
recently conducted studies report a variable proportion of 
patients with RBBB ≤18%. Thus, these patients represent a 
sizeable subgroup in need of adjunct therapies on top of the 
best pharmacological therapy. This percentage is most likely 
an underestimation of the true number of patients with heart 
failure and RBBB, because CRT in patients with RBBB has 
been controversial from the beginning, although QRS widen-
ing ≥120 ms was the only ECG selection criterion for CRT. 
More recently, several studies have shown that non-LBBB 
patients benefit less from CRT than those with LBBB.20,21 As 
a consequence, European Society of Cardiology guidelines 
indicate the use of CRT in non-LBBB patients with a QRS 
duration >150 ms at class IIa/level of evidence B, whereas 
guidelines suggest the use of CRT in non-LBBB patients with 
a QRS duration between 120 and 150 ms at a lower recom-
mendation class (class IIb, level of evidence B).22
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Although several factors may be held accountable for the 
diverse response to CRT in RBBB compared with LBBB, they 
have not been systematically reviewed. However, several ret-
rospectively conducted studies have suggested that CRT may 
be beneficial in subgroups of patients with RBBB. In the pres-
ent article, we are taking a mechanistic approach to evaluate 
the effect of CRT in patients with heart failure diagnosed with 
RBBB. Thus, we will review the electrophysiological findings, 
the mechanical abnormalities observed in patients with RBBB, 
and finally the clinical results of CRT in this patient subgroup to 
address a key question: is RBBB an inappropriate indication for 
CRT or is CRT applied in the wrong way in patients with RBBB?
Right and Left Ventricular Electric Activation in 
Patients With RBBB
The relative fragility and mechanical structure of the right-
sided conduction system may explain the high incidence of 
this conduction delay in the general population without evi-
dence of structural heart disease. In the Framingham study, 
RBBB and LBBB developed in 70 and 55 patients, respec-
tively, during 18-year follow-up in 5826 healthy individuals.23 
The Moli-sani study, which recruited 24 090 subjects in the 
central-southern region of Italy,24 reported that RBBB was 
recorded in 589 individuals (2.44%), whereas LBBB was 
recorded in 181 individuals (0.75%); interestingly, RBBB was 
more frequent in men (3.4%) than in women (1.0%), whereas 
LBBB was slightly more frequent in women (0.9%) than in 
(Circ Arrhythm Electrophysiol. 2014;7:532-542.)
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men (0.6%). Furthermore, new onset of RBBB in patients 
with heart disease may be indicative of aggravation of the 
heart condition25 and possible association with right ventricu-
lar (Rv) dysfunction of primary or secondary origin.
Insight into electric activation during LBBB and during ven-
tricular pacing (including CRT) has steadily increased during 
the past years. In contrast, detailed 3-dimensional mapping in 
patients with RBBB is limited to a single case series published 
by Fantoni et al26 in 2005. These authors performed extensive 
measurement of both Rv and left ventricular (Lv) endocar-
dial electric activation in heart failure patients with RBBB 
and LBBB. In heart failure patients with RBBB, the earliest 
ventricular activation site is located in the Lv myocardium, 
usually in the septum. The Lv septal activation coincides with 
the beginning of the QRS complex. After a considerable delay 
(50–70 ms), the activation arrives at the Rv side of the septum 
because of slow left-to-right transseptal activation. The elec-
tric activation of the entire Rv occurs slowly, most likely as a 
result of cell-to-cell conduction: from the septal breakthrough 
site, the activation front proceeds toward the Rv anterior wall 
and then to the right lateral wall and the outflow tract, which 
both are the latest activated regions. Because of this activa-
tion pattern, Rv anterior and lateral regions are delayed with 
respect to the onset of the QRS complex, thus mirroring on 
the right side of the heart the pattern that is usually observed 
in the Lv of patients with LBBB (Figure 1). As a result, total 
Table 1. Proportion of Patients With Conduction Abnormality Included in Selected Prospective and 
Observational Cardiac Resynchronization Therapy Studies
Study
Year of  
publication NYHA Class
Mean
LVEF
Mean QRS 
Duration
Total number 
of patients
Proportion of patients 
with  
conduction abnormality
LBBB RBBB IVCD
Prospective randomized studies*
  PATH-CHF I1 2002 3–4 21±6 174±30 42 93% 7% 0%
  PATH-CHF II2 2003 2–4 23±7 155±20 86 88% 5% 6%
  CONTAK CD3 2003 2–4 21±7 155±27 490 54% 14% 33%
  MIRACLE4 2004 3–4 22±6 166±21 453 80% 11% 9%
  MIRACLE ICD II5 2004 2 25±7 166±24 186 NA 17% NA
  COMPANION6 2004 3–4 22 158 1520 71% 11% 18%
  CARE-HF7 2005 3–4 25† 160† 813 94% 5% 1%
  REVERSE8 2008 1–2 26±7 151±23 680 54% 8% 19%
  MADIT-CRT9 2009 1–2 24±5 152±18 1817 70% 13% 17%
  RAFT10 2010 2–3 23±5 158±24 1866 69% 9% 11%
Observational studies*
  Wokhlu11 2009 2–4 23±7 158±31 338 67% 11% 13%
  Adelstein12 2009 3–4 23±9 175±30 636 64% 9% NA
  Rickard13 2010 2–4 22±8 156±20 335 61% 11% 28%
  Bilchick14 2010 1–4 23±6 157±26 14946 69% 11% 20%
  Varma15 2011 2–4 23±8 163±21 120 45% 26% NA
  Leong16 2012 3–4 26±8 161±19 561 84% 16% 0%
  Hara17 2012 3–4 NA 160±26 254 50% 18% 32%
  Kandala18 2013 3–4 23±6 156±28 144 57% 13% 30%
Survey*
  Dickstein19 2009 1–4 27±8 157±32 2438 68% 6% NA
CARE-HF indicates Cardiac Resynchronization-Heart Failure; COMPANION, Comparison of Medical Therapy, Pacing and Defibrillation 
in Heart Failure; ICVD, intraventricular conduction disturbance; LBBB, left bundle branch block; LVEF, left ventricular ejection fraction; 
MADIT-CRT, Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy; MIRACLE, Multicenter 
InSync: Randomized Clinical Evaluation; MIRACLE II, Multicenter InSync ICD II: Randomized Clinical Evaluation; NA, not available; 
NYHA, New York Heart Association; PATH-CHF I, Pacing Therapies in Congestive Heart Failure I; PATH-CHF II, Pacing Therapies in 
Congestive Heart Failure II; RAFT, Resynchronization-defibrillation for Ambulatory heart Failure Trial; RBBB, right bundle branch block; 
and REVERSE, Resynchronization reVErses Remodeling in Systolic left vEntricular dysfunction. 
*Prospective randomized controlled studies are reported using the respective acronym, whereas the observational studies and survey 
are reported according to the first author of the published article.
†Median value instead of mean value has been reported.
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Rv endocardial activation time in patients with RBBB is much 
longer (80–120 ms) than in patients without conduction delays 
(50–80 ms). Because in RBBB much or all of the Rv undergoes 
depolarization after activation of the Lv has been completed, 
the electric forces generated by the Rv are not masked by the 
predominant and largest Lv electric forces but now show up as 
a delayed component in the QRS complex, drawing the char-
acteristic RBBB morphology in the surface ECG (Figure 1).
In some heart failure patients with RBBB, the QRS mor-
phology is significantly different from the characteristic RBBB 
appearing in otherwise structurally normal hearts. These 
patients with heart failure show a specific electrocardiographic 
pattern defined by Rosenbaum et al27 as RBBB masking LBBB, 
characterized by a broad, slurred, sometimes notched R wave 
on leads I and avL, together with a leftward axis deviation 
frequently noted in LBBB QRS morphology patients as well 
(Figure 1). In patients with RBBB masking LBBB, electroana-
tomic mapping data have demonstrated that not only Rv acti-
vation is abnormally delayed but also Lv activation is delayed 
as much as in patients presenting with LBBB.26 Furthermore, 
the Lv activation pattern observed in these patients resembles 
the one observed in patients with LBBB (Figure 1). notably, 
patients with heart failure presenting with pure RBBB differed 
from those with RBBB masking LBBB by presenting an 
Lv anterobasal breakthrough in addition to the septal one 
(Figure 1). patients with RBBB masking LBBB usually pres-
ent with a severe biventricular postischemic cardiomyopathy, 
with large myocardial injury because of significant lesion of 
the anterior descending coronary artery.
RV and LV Mechanical Abnormalities in Animals 
and Patients With RBBB
Canine studies using experimental LBBB have shown that this 
intervention immediately and persistently reduces Lv pump 
function.28,29 In this regard, less is known about the hemo-
dynamic effect of RBBB. In the 1980s, yasui et al30 induced 
experimental RBBB in dogs with normal hearts and in dogs 
with moderate and severe Rv hypertrophy. They found minor 
influence of RBBB on Rv and Lv pump function in normal 
hearts, but significant deterioration if occurring in hearts with 
Rv hypertrophy: RBBB increased Rv end-diastolic pressure, 
Rv dP/dtmax, and stroke volume. This deterioration was 
related to the duration of the QRS complex.30 In this model, Lv 
function was hardly affected. These data are important because 
they indicate that RBBB may affect Rv function, the forgot-
ten ventricle; however, few data are available on Rv systolic 
A
B
C
Figure 1. Electroanatomic mapping and surface 12-lead ECG in a patient with right bundle branch block (RBBB; A), in a patient with 
RBBB masking left bundle branch block (LBBB; B), and in a patient with LBBB (C). The activation sequence is color-coded by 10-ms 
isochrones (red indicates the earliest activation region, and purple indicates the latest activation region).
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function in patients with heart failure, alone or in combina-
tion with RBBB, LBBB, and CRT. However, it is important to 
notice that Rv hypertrophy is rarely observed in adults patients 
with systolic heart failure; therefore, it makes it difficult to 
completely translate in patients the observation by yasui et al.30
Byrne et al31 investigated mechanical dyssynchrony in 
a canine model of RBBB and LBBB in combination with 
tachypacing-induced heart failure. With LBBB, there was a 
septal shortening and lateral stretch during early systole fol-
lowed by septal stretch and lateral shortening later in systole. 
However, with RBBB, strain was more uniform with little dys-
synchrony in early systole and posteroseptal shortening in late 
systole without reciprocal stretch. plots of instantaneous strain 
versus short-axis segment location (representing an instan-
taneous distribution of strain throughout all myocardial seg-
ments at 2 different time points in the cardiac cycle) showed a 
more sinusoidal strain profile during early systole in the LBBB 
model, reflecting a larger disparity of strains. For the RBBB 
case, segment-to-segment variation was noted in late systole 
but was lower in magnitude than that seen with LBBB. Early 
systolic strain distribution in RBBB was nearly uniform..31
In heart failure patients with RBBB with an indication for 
CRT, the mechanical abnormalities of right and left ventricle have 
been rarely reported.17,32 Hara et al17 examined 278 patients with 
heart failure with any kind of ventricular conduction disturbance 
and compared the echocardiographic characteristics (assessment 
of interventricular mechanical delay and speckle-tracking radial 
strain) with outcome after CRT. patients with LBBB had the most 
prevalent and significant degree of radial strain dyssynchrony 
compared with non-LBBB patients, and patients with RBBB 
had the least dyssynchrony, even if QRS duration was compa-
rable in patients with LBBB and RBBB. In patients with LBBB, 
peak radial strain occurred earlier in the anteroseptum and later 
in the posterior wall than in non-LBBB patients. Lv pre-ejec-
tion delay and interventricular mechanical delay were greatest 
in patients with LBBB, but Rv pre-ejection delay was greatest 
in patients with RBBB, whereas the interventricular mechanical 
delay was usually small in patients with RBBB. All these data 
indicate minor Lv involvement in many patients with RBBB but 
indeed possible involvement of Rv function. Importantly, 17 of 
45 patients with RBBB did show Lv radial strain dyssynchrony 
(>130 ms), which might be associated with left anterior hemi-
block or other Lv conduction abnormalities on top of the RBBB.
Outcome of Patients With RBBB
Morbidity and mortality of heart failure patients with RBBB 
QRS pattern are high, although comparative data from epide-
miological studies show a slightly better prognosis for patients 
with RBBB than for patients with LBBB. The Italian network 
on Congestive Heart Failure Registry included 5517 patients 
with heart failure of different causes.33 data derived from the 
Italian network on Congestive Heart Failure database showed 
that the total 1-year mortality in patients with RBBB was equal 
to that in patients with narrow QRS complex (11.9%), yet sig-
nificantly lower than in patients with LBBB (16.1%); notably, 
patients with RBBB more frequently presented with heart 
failure of ischemic cause, whereas primary dilated cardiomy-
opathy was the most frequent cause of heart failure in patients 
presenting with complete LBBB. Furthermore, outpatients 
with complete RBBB were older and more frequently had car-
diac enlargement and a reduced EF, but RBBB was not cor-
related with a more symptomatic heart failure. Similarly, data 
from the Enhanced Feedback for Effective Cardiac Treatment 
(EFFECT) study showed that LBBB and RBBB conferred an 
increased unadjusted risk of adverse outcomes, but LBBB was 
the only significant predictor of death in 1 and 5 years.34
The most compelling data about absolute and relative lower 
hospitalization rate and death rate in heart failure patients with 
RBBB compared with LBBB have been recently published 
by Zareba et al20 for the implantable cardioverter-defibrillator 
(control) group of the Multicenter Automatic defibrillator 
Implantation Trial With CRT (MAdIT-CRT) study. notably, 
MAdIT-CRT patients differed from the Italian network on 
Congestive Heart Failure Registry patients because they had a 
lower functional class (new york Heart Association class I or II), 
had no history of atrial fibrillation, and had no previous major 
ventricular arrhythmias. The MAdIT-CRT investigators pre-
sented cumulative probabilities of primary end points, consisting 
of heart failure event or death, and the secondary end point of 
death in each conduction groups and according to device type. 
The patients with LBBB had a nonsignificantly higher risk of pri-
mary end points at 3 years compared with the patients with RBBB 
and intraventricular conduction disturbance (32% versus 19% 
versus 23%, respectively), a difference that was mainly driven 
by differences in heart failure events (Figure 2). Interestingly, the 
risk of the combined end point of either ventricular tachycardia or 
ventricular fibrillation requiring appropriate therapy or death was 
not different between LBBB (31%) and RBBB (28%; Figure 2).
CRT in a Preclinical RBBB Model
The differential effect of biventricular pacing in the preclini-
cal setting of RBBB or LBBB has been reported by Byrne 
et al.31 These investigators showed that the improvement in 
synchrony (and function) with CRT in hearts with RBBB 
was less than in those with LBBB. In the acute setting, both 
Lv dP/dtmax and stroke work increased by 5% to 10% in 
the RBBB hearts, which is less than half of the increase in 
LBBB hearts.35,36 notably, the mode of CRT did not neces-
sarily require biventricular stimulation. Single-site Rv pacing 
produced similar improvements in global mechanical func-
tion and synchrony as with biventricular pacing. Interestingly, 
significant narrowing of the QRS complex with both Rv-only 
and biventricular pacing did not translate to a large functional 
improvement. These findings are reminiscent of the effects of 
biventricular and Lv pacing in LBBB hearts, supporting the 
idea that in CRT pacing of the latest activated ventricle domi-
nates its benefit. An important observation was that Rv and 
biventricular pacing also, more prominently, improved RvEF, 
suggesting that CRT with underlying RBBB may especially 
involve improvement of Rv function.
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CRT in Patients With RBBB
during the past 10 years, there have been some observational 
studies in patients with RBBB, most of them including ≤100 
patients, which assessed the effect of CRT on some surrogate 
end points of mortality and few on morbidity and mortality 
directly. Rickard et al13 observed that patients with RBBB who 
received CRT derived less cardiac reverse remodeling and less 
symptomatic improvement compared with patients with LBBB. 
Egoavil et al37 followed up 61 patients with RBBB randomly 
assigned to CRT or no CRT and found no improvement in aero-
bic capacity (measured by maximal oxygen consumption) after 
6 months. Wokhlu et al11 and Adelstein and Saba12 demonstrated 
that patients with RBBB receiving CRT had a higher mortality 
rate and increased progression of heart failure (to transplant or 
assist device implantation) compared with patients with LBBB.
More recently, the results of 2 large US registries including 
patients with LBBB, intraventricular conduction disturbance, and 
RBBB have been published. Bilchick et al14 used the data from the 
Medicare ICd Registry between 2005 and 2006 to characterize 
prognosis after CRT defibrillator (CRT-d) and to assess the rela-
tionship between clinical factors measured at the time of implan-
tation and outcomes after CRT-d in ≈15 000 Medicare patients.14 
In particular, they tested the hypothesis that patients with RBBB 
have significantly worse outcomes after CRT-d implantation than 
those with LBBB. Among all patients receiving CRT-d, RBBB 
morphology was among the most powerful predictors of outcome, 
even after adjustment for QRS width and other covariates. RBBB 
had significantly higher short-term and long-term adjusted haz-
ards for death among all patients with CRT-d. RBBB had twice 
the adjusted hazard for death (hazard ratio [HR], 1.99; P=0.001) 
as LBBB. An even larger study also using Medicare data between 
2006 and 2009 explored the outcome in 24 169 patients receiving 
CRT-d. This study showed that mortality was lowest in patients 
with LBBB and QRS duration >150 ms and worse in LBBB with 
QRS duration of 120 to 149 ms (HR, 1.30) and even worse in 
patients with non-LBBB morphology with QRS duration >150 
ms (HR, 1.34) and 120 to 149 ms (HR, 1.52).21
As far as meta-analysis is concerned, Sipahi et al38 performed a 
large meta-analysis on randomized CRT trials with a total of 5356 
patients. Within this study, 1233 patients had non-LBBB conduc-
tion abnormalities that were randomly assigned to CRT or no-CRT, 
a size that is comparable with the major individual CRT trials such 
as Comparison of Medical Therapy, pacing and defibrillation in 
Heart Failure (CoMpAnIon) and Cardiac Resynchronization-
Heart Failure (CARE-HF). They found that there was no trend 
for reduction in clinical events in this non-LBBB patient category. 
However, it important to emphasize that this meta-analysis was 
of little value to establish the role of CRT in patients with RBBB 
because it was underpowered to estimate the clinical effects of 
patients with RBBB alone as evidenced by a relatively wide 95% 
confidence interval (0.69–1.20) for a meta-analytic HR.
Taken together, none of the observational studies and the 
meta-analysis published till date were able to demonstrate 
Figure 2. Two patient examples of different right bundle branch block (RBBB) morphology (A, RBBB masking left bundle branch block 
[LBBB]; B, RBBB without LBBB) and radial strain dyssynchrony, with ejection fraction (EF) response and long-term outcome after cardiac 
resynchronization therapy (CRT). Reproduced from Hara et al17 with permission of the publisher (Oxford University Press, 2012).
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a significant CRT benefit in patients with RBBB. However, 
if one considers the MAdIT-CRT study results in the con-
trol arm, which showed a better outcome in RBBB than in 
LBBB patients but a larger mortality in RBBB CRT-treated 
patients than in LBBB CRT-treated patients observed in both 
Medicare registries, one may even think of an excess in mor-
tality because of CRT in patients with RBBB.
CRT in a Subset of Patients With RBBB
Having said this, all above does not completely rule out mod-
erate improvements in subsets of patients with RBBB. Sev-
eral studies have characterized such patient subsets, either by 
echocardiographic criteria or by specific ECG pattern. In one 
of the earliest case series, Garrigue et al39 reported a benefi-
cial response to CRT (eg, reduced Lv end-diastolic diameter, 
decreased mitral regurgitation, and improved aortic time-veloc-
ity integer) but only in RBBB subjects with concomitant Lv 
intraventricular dyssynchrony. Chandra et al40 reported in 
44 patients that the presence of concomitant left hemiblock 
among patients with RBBB referred for CRT was associated 
with greater response to therapy (defined as improvement in 
LvEF ≥5% or new york Heart Association class). varma15 
studied the inferolateral Lv activation delay, as measured by 
the distance between QRS onset and the intrinsicoid of the 
Lv ECG in patients with Lv dysfunction and RBBB versus 
LBBB. In that study, the QRS duration correlated well with 
the inferolateral Lv activation delay in both groups, although 
somewhat more strongly in patients with LBBB. Therefore, 
at wider QRS durations, patients with non-LBBB morpholo-
gies are likely to have significant Lv activation delay, an elec-
tric substrate amenable to resynchronization. Similarly, in a 
more recent study, it has been shown that in the subgroup of 
RBBB patients with mechanical dyssynchrony (radial strain) 
similar to those of the patients with LBBB, a much favorable 
response to CRT as given by death, implantation of ventricular 
assist device, and heart transplantation was found.17 Also, the 
increase in LvEF and the reduction of end-systolic volume in 
patients with RBBB showing radial dyssynchrony were simi-
lar to that noticed in typical patients with LBBB. In contrast, 
those RBBB patients without significant radial dyssynchrony 
showed an unchanged LvEF and even a progression of Lv 
remodeling process.17 Kandala et al18 have recently reported 
about the use of Lv lead electric delay (LvLEd), measured 
intraprocedurally as the interval between QRS onset on the 
surface ECG to the peak of sensed electrogram on Lv lead. 
Among 144 patients, heart failure hospitalization was higher in 
non-LBBB compared with LBBB patients (43.5% versus 24%; 
P=0.015). However, in both LBBB and non-LBBB patients, 
those with long LvLEd had a lower heart failure hospitaliza-
tion than those with short LvLEd (36% versus 61%; P=0.026). 
In adjusted Cox proportional hazards model, the long LvLEd 
in LBBB and non-LBBB was associated with an improved 
outcome. Specifically, in non-LBBB, LvLEd ≥50% of QRS 
duration was associated with improved event-free survival 
with respect to time to first heart failure hospitalization (HR, 
0.34; P=0.011) and composite outcome (HR, 0.41; P=0.019). 
Finally, the most recent report by the MAdIT-CRT investi-
gator41 found that subjects with RBBB without left anterior 
fascicular block experienced greater improvement in cardiac 
function after 12 months of CRT-d than those with left anterior 
fascicular block. In contrast, there was no difference in clini-
cal outcomes (ie, death or heart failure admissions) between 
RBBB subjects with or without a left anterior fascicular block 
pattern on the surface ECG, despite significant improvements 
in cardiac function by echocardiography. Therefore, this study 
seems to run counter to the aforementioned studies, because 
a close reading of Figure 1 of Tompkins et al41 shows that 
the patient presenting with left anterior fascicular block also 
has ECG features of the so-called RBBB masking LBBB by 
Rosenbaum et al27: broad, slurred, sometime notched R wave 
on leads I and AvL, with a leftward axis deviation. There is no 
clear explanation for these apparently opposite findings.
In previous studies, the CircAdapt model of the human heart 
and circulation (www.circadapt.org) proved to be a useful tool 
to investigate the mechanism of CRT in heart failure patients 
with LBBB.42,43 Here, we used the CircAdapt model to simulate 
CRT in the failing heart with different degrees of RBBB, LBBB, 
or with a combination of both conduction abnormalities. First, 
a simulation of a failing heart with decreased ventricular con-
tractility and synchronous ventricular activation was obtained as 
described previously.43 Second, different degrees of RBBB were 
simulated by imposing dyssynchronous Rv free wall activation 
up to a maximal local activation delay of 156 ms. In addition, dif-
ferent degrees of (coexistent) LBBB were simulated by imposing 
a septal-to-lateral wall activation delay up to a maximum value of 
180 ms. Finally, CRT was applied by imposing the same biven-
tricular pacing protocol to all simulations as published previously 
by Lumens et al.43 Figure 3 summarizes all the baseline activa-
tion sequences simulated and also illustrates the general activa-
tion pattern used for CRT. Furthermore, Figure 3 shows for all 
simulations the acute hemodynamic response to CRT, defined as 
the relative change of stroke volume with respect to baseline (63 
mL). Table 2 summarizes global cardiac function during baseline 
and after CRT for the synchronous failing heart (no dELAy) 
and for 3 dyssynchronous failing hearts (RBBB 156, LBBB 180, 
and RBBB 156 and LBBB 180). In general, these simulation data 
support the previously reviewed clinical observations that pure 
RBBB without Lv electric dyssynchrony is not a substrate that 
should be treated with conventional CRT. only when sufficient 
Lv dyssynchrony substrate coexists, however, acute response to 
CRT increases to clinically relevant positive values.
Implication for the Deployment of CRT in Patients 
With RBBB
After reviewing the available data on RBBB, there is a 
legitimate question to be addressed: is RBBB an inappropri-
ate indication for CRT or is CRT applied wrong in patients 
with RBBB? The suitability of CRT for a patient subgroup, 
such as RBBB, is important because the therapy is relatively 
expensive and it comes with some potential complications. 
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More importantly, a CRT nonresponse may actually imply an 
adverse effect of the therapy on cardiac function.17 After all, 
application of biventricular pacing in a heart with perfectly 
normal ventricular conduction widens QRS duration and 
reduces contractility.42 Recent CRT studies in patients with 
narrow QRS complex support this view.44,45 Because in iso-
lated RBBB the Lv conduction is normal, biventricular pac-
ing may prolong Lv activation and thus reduce Lv function. 
In canine failing RBBB hearts, Rv and biventricular pacing 
resulted in only minor acute improvements in Lv function,31 
which may not justify the costs and risks of applying CRT. All 
these arguments support the opinion that RBBB is a wrong 
indication for CRT. Whether some pacing therapy may be 
beneficial by pacing at 1 (free wall of right ventricle) or mul-
tiple areas (free wall and outflow tract of right ventricle) of 
electric delay is unknown.
However, several factors strongly suggest that CRT is deliv-
ered in a wrong way in hearts with RBBB. Because RBBB 
predominantly affects Rv function, patients with poor Rv 
function may benefit from CRT, and this is a virtually unstud-
ied area. Furthermore, to create the best resynchronization in 
the Rv, the commonly used pacing site (Rv apex) may not be 
optimal because electroanatomic maps show that the Rv lat-
eral wall is latest activated.26 Therefore, the benefit of implant-
ing a pacing lead at a lateral site rather than at the apex should 
be investigated, together with the usefulness of pacing the Rv 
outflow tract with a second lead. Although these possibilities 
improve the application of CRT in patients with RBBB, con-
ventional CRT may be effective in the subgroup of patients with 
RBBB who also have a delayed Lv activation. Therefore, we 
hypothesize that individualized treatment strategies shall be 
used based on the presence of Lv and Rv dyssynchrony dem-
onstrated either by advanced echocardiographic techniques or 
by surface ECG. Admittedly, the proposed treatment options 
have been mechanistically developed (Figure 4), thus requiring 
confirmation in larger prospective studies. These studies should 
Figure 3. Acute hemodynamic response 
to conventional biventricular (BiV) pacing 
in various computer simulations of a 
failing heart with synchronous ventricular 
activation, right bundle branch block 
(RBBB), left bundle branch block (LBBB), 
or a combination of RBBB and LBBB. 
Note that cardiac resynchronization 
therapy (CRT) hardly improves or even 
deteriorates cardiac pump function 
in hearts with RBBB in the absence 
of sufficient coexistent left ventricular 
(LV) activation delay. RV indicates right 
ventricular; and RVA, right ventricular 
apex.
Table 2. Global Cardiac Function During Baseline and After CRT for the Synchronous Failing 
Heart and for 3 Dyssynchronous Failing Hearts Presenting With RBBB and LBBB
Function Index
NO DELAY RBBB 156 LBBB 180
RBBB 156 and 
LBBB 180
Baseline* CRT Baseline* CRT Baseline* CRT Baseline* CRT
HR, bpm 80 80 80 80 80 80 80 80
AV delay, ms 150 150 150 150 150 150 150 150
SV, mL 63 59 63 63 63 73 63 75
RVEF, % 38 37 36 36 28 33 29 33
LVEF, % 30 29 30 29 25 29 26 29
LVEDP, mm Hg 24 23 24 27 42 39 40 40
The value of conduction delay within each ventricle is arbitrary and is indicated in milliseconds. AV delay indicates 
atrioventricular delay; CRT, cardiac resynchronization therapy; HR, heart rate; LBBB, left bundle branch block; LVEDP, left 
ventricular end-diastolic pressure; LVEF, left ventricular ejection fraction; NO DELAY, synchronous failing heart; RBBB, right 
bundle branch block; RVEF, right ventricular ejection fraction; and SV, stroke volume.
*Homeostatic control was active during all baseline simulations so that mean arterial pressure and cardiac output were 
constant (ie, 92 mm Hg and 5 L/min, respectively) in these simulations.
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include detailed echocardiographic evaluation of both Rv and 
Lv function and strain analysis for patient selection as well as 
to better characterize the immediate, short-term, and long-term 
effect on cardiac mechanics of each of the proposed novel pac-
ing configurations. Further tools that may support the mecha-
nistic approach could be the determination of delay between Q 
wave and Lv electrogram (Q-Lv time; also known as LvLEd) 
or even more elegantly using noninvasive electric mapping.46 
obviously, simulation tools such as the CircAdapt model can 
also be used to investigate relative effectiveness of different 
pacing strategies in subsets of patients with heart failure.
Conclusions
The available evidence indicates that straightforward appli-
cation of CRT in patients with RBBB should be discour-
aged. However, additional studies should be performed as to 
whether a subset of patients with RBBB may benefit from 
CRT. For this purpose, a pooled analysis on individual patient 
data with RBBB QRS morphology from all recent major CRT 
trials (eg, MAdIT-CRT, Resynchronization-defibrillation for 
Ambulatory heart Failure Trial [RAFT], Resynchronization 
revErses Remodeling in Systolic left vEntricular dysfunction 
[REvERSE]) is urgently needed. The analysis should look at 
hard and soft outcomes and also examine subsets within the 
RBBB population, including cause of underlying cardiomy-
opathy and presence of left fascicular block. The results of the 
analysis may then direct further research, perhaps indicating 
a need for randomized trials in such subsets of patients with 
RBBB. We acknowledge, however, the difficulty in conduct-
ing a trial in patients with RBBB because of the rarity of the 
population and the possibly long-term follow-up needed to 
demonstrate some differences between patients with LBBB 
versus RBBB and within the RBBB population. Alternatively 
and additionally, mechanistic studies are required to charac-
terize the effect of resynchronization on systolic and diastolic 
function of right and left ventricles better with multiple Rv 
leads or alternative Rv/Lv lead positions.
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Figure 4. Mechanistically based flow chart indicating possible implantation strategies in cardiac resynchronization therapy (CRT) 
patients presenting with right bundle branch block and electric or mechanical activation delay of the left ventricle (LV). RV indicates right 
ventricular.
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Response to Angelo Auricchio, MD, PhD, Joost Lumens, PhD, and Frits W. Prinzen, PhD
Kenneth C. Bilchick, MD, MS
In the companion paper, Auricchio et al have taken the position that cardiac resynchronization therapy (CRT) has a signifi-
cant role in patients with heart failure (HF) and right bundle branch block (RBBB). This response will highlight the influence 
of left-sided conduction system disease on electric and mechanical activation in HF with RBBB and the impact of the CRT 
pacing strategy in these patients.
physiological experiments in HF with RBBB without left-sided conduction system disease (pure RBBB) indicate that 
left ventricular (Lv) free wall pacing is unlikely to improve hemodynamics in this situation. In fact, right ventricular pacing 
alone (without Lv free wall pacing) has been shown to have potential benefits for both Lv and right ventricular hemodynam-
ics in HF with RBBB. This contrasts with the hemodynamic benefits demonstrated for Lv free wall pacing in left bundle 
branch block (LBBB).2 These physiological data are supported by large registry studies showing that patients with RBBB or 
non-LBBB have worse outcomes after CRT than patients with LBBB.
despite these negative results for CRT in RBBB, there is still interest in whether it may be possible to identify a small 
subset of patients with RBBB who may benefit from CRT. In fact, coronary sinus recordings from the basal inferolateral Lv 
in patients with HF have shown that some patients with RBBB have moderately prolonged electric timing in this area relative 
to QRS onset, although only patients with LBBB had activation times >160 ms in this region. A small electric mapping study 
provides insights into electric activation in the case of RBBB with concomitant left-sided conduction system or what has 
also been termed LBBB masquerading as RBBB. In this mapping study, the presence of only a single electric breakthrough 
site on the posterior Lv septum (rather than both anterior and posterior breakthrough sites) in a patient with RBBB and left 
anterior fascicular block was associated with anterior Lv activation timing that was about as late as the right ventricular free 
wall. In this regard, it is interesting that a subgroup analysis of the Multicenter Automatic defibrillator Implantation Trial 
With CRT (MAdIT-CRT) trial has shown that RBBB patients with left anterior fascicular block experience suboptimal out-
comes compared with other patients with RBBB, such as those with concomitant left posterior fascicular block. It is possible 
that the latest activated sites in the patients with left anterior fascicular block were anterior and that the best Lv pacing sites 
were not targeted for these patients. In any case, this highlights the potential use of advanced cardiac imaging for mapping 
electric and mechanical activation in patients with HF and non-LBBB.
In summary, both clinical and physiological studies for CRT in RBBB indicate that CRT as it is typically implemented is 
much less likely to improve outcomes in patients with HF associated with RBBB relative to patients having HF with LBBB. 
Additional studies that investigate novel ways to implement CRT in patients with RBBB and use advanced cardiac imaging 
hold promise for improving outcomes in patients with HF and non-LBBB conduction delays.
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